Market News - Page 255

Financial Report for the Half Year ended 30 June 2022…

The Board of Darktrace notes the recent media speculation and confirms that, following receipt of a number of preliminary and conditional proposals, it is in the early stages of discussions with Thoma Bravo, L.P. (“Thoma Bravo”) regarding a possible cash offer for the entire issued and to be issued share capital of the Company….

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces a trading update for the year ending 30 September 2022. …

Enhertu significantly delayed disease progression in DESTINY-Breast02…

Haleon plc (LSE: HLN) notes the recent volatility in its share price and is aware of market speculation on Haleon's potential liability in respect of Zantac product liability litigation. …

FDA and EMA have Concluded there is no evidence of a casual association between ranitidine therapy and the development of cancer….

The Directors of Murray International Trust PLC report the unaudited results of the Company for the six months ended 30 June 2021….

Enhertu approved in the US as the first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer…